Dr. Stulting is a pioneer in corneal disease research and LASIK and serves as the Director of Corneal Disease & Research at Woolfson Eye Institute. With an illustrious career spanning more than 30 years, his basic research efforts have opened the doors to a deeper understanding of the mechanisms of corneal transplant rejection and herpetic ocular disease and new treatment paradigms. He chaired the Ophthalmic Devices Panel, an advisory group to the FDA, for three years and served as a member for ten.
As an experienced surgeon and medical monitor, Dr. Stulting is overseeing a clinical trial using a new intraocular telescope for patients with cataract and severe central vision loss from macular degeneration. He is one of the most frequently cited investigators in the field, authoring more than 200 publications and countless other articles based on his extensive clinical research in corneal transplantation, laser treatment of refractive errors - LASIK, the management of dry eye, and cataract surgery. He is a revered authority for patients with complex issues that generate difficult questions about refractive surgery outcomes and is a sought-after speaker on both refractive surgery and cornea topics.
Dr. Stulting conducts basic and clinical research in corneal disease, corneal transplantation and refractive surgery. He participated in the first physician-sponsored clinical investigation of LASIK, prior to the refractive laser’s approval in the United States by the Food and Drug Administration (FDA). He is a leader in the investigation of new laser technologies for the treatment of damaged corneas and Principle Investigator for a clinical trial of a new technology that is likely to revolutionize the management of keratoconus—a disease that today accounts for 20% of the corneal transplants performed in the United States. He has also organized a key multi-center clinical trial to evaluate the effect of tissue typing on corneal transplantation.
Prior to joining Woolfson Eye Institute, Dr. Stulting was the medical director of Emory Vision – Emory University’s refractive surgery center. He has trained more than 60 fellows in his sub-specialty and countless residents, many of whom have gone on to distinguish themselves in the profession.
Dr. Stulting served as Editor-in-Chief of Cornea: The Journal of Cornea and External Disease and is the Immediate Past President of the American Society of Cataract and Refractive Surgery. He is a member of the Board of Directors of the Eye Bank Association of America, and a member of the Board of Directors of the Georgia Eye Bank. Dr. Stulting has received the FDA’s citation for Excellence, Commitment and Outstanding Service in Protecting the Public Health, the prestigious Paton Award from the Eyebank Association of America, and the American Academy of Ophthalmology’s Lifetime Achievement Award. He also delivered the Leopold Lecture at Wills Eye Hospital in Philadelphia and the Paton Lecture at Baylor University in Houston.
Dr. Stulting graduated from Duke University with BS, MD, and PhD degrees. He was an intern and resident in internal medicine at Washington University, a resident in ophthalmology at Bascom Palmer Eye Institute, and a Fellow in Cornea and External Disease at Emory University – recently retiring from Emory University as Hughes Professor of Ophthalmology and Director, Section of Cornea, External Disease and Refractive Surgery.
As a licensed private pilot (for 36 years), he enjoys flying his Bonanza A-36. He also enjoys dancing, hiking, mountain biking, and loves the out-of-doors.